PLYMOUTH MEETING, Pa., Dec. 12 /PRNewswire-FirstCall/ -- Genaera
Corporation (Nasdaq: GENR) today announced that Jack Armstrong, President
and Chief Executive Officer of Genaera, is scheduled to present at the 2007
RBC Capital Markets Healthcare Conference. The presentation is part of an
RBC Capital Markets' panel discussion of diabetes and obesity, entitled,
"The Pharmaceutical Sweet Spot: Diabetes & Obesity," and will take place in
New York on Thursday, December 13 at 10:00 a.m. ET.
This panel presentation is being webcast at: http:/www.wsw.com/webcast/rbc84qpanel23
Genaera Corporation is focused on advancing the science and treatment of metabolic diseases. The Company has significant market opportunities with a first-in-class molecule, trodusquemine (MSI-1436), that has the potential to redefine the treatment paradigm for obesity and type 2 diabetes and is presently in a Phase 1 trial in obesity. In addition, Genaera has a value- driven, fully out-licensed partnership with MedImmune, Inc. for a second core program that is presently undergoing Phase 2 clinical testing in asthma. Genaera is committed to directing resources to its core program and the aggressive clinical development of its key assets to build stockholder value. For further information, please see our website at http://www.genaera.com.
|SOURCE Genaera Corporation|
Copyright©2007 PR Newswire.
All rights reserved